Steven R. Zeldenrust, MD, PhD | oneAMYLOIDOSISvoice
Healthcare Professionals

Steven R. Zeldenrust, MD, PhD (Deceased)

Healthcare Professional
Division of Hematology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

Steven R. Zeldenrust, age 56, of Rochester, passed away on Wednesday, July 10, 2019, after a long battle with cancer. Steve is survived by his wife of 31 years, Deb (Peterson); sons, Jon (Megan) and Eric (Abbey); grandsons, Theodore and Micah; mother, Joan (Ridder); and sisters, Lauree (Wayne) Pondinas and Mary (John) Rosenbaum.

Steven R. Zeldenrust was a Hematologist at Mayo Clinic, Rochester, Minnesota. He completed his graduation from Hope College in chemistry followed by MS from Purdue University and MD from Indiana University School of Medicine. Dr. Zeldenrust completed his Residency in Internal Medicine and Fellowship in Hematology and Oncology from Mayo Clinic College of Medicine. His interest areas included amyloidosis, including the clinical aspects and pathophysiology of the disease. His research focus was the treatment of patients with amyloidosis and myeloma. His laboratory research focused on mechanisms of amyloid protein toxicity. He also conducted clinical trials in the area of familial amyloidosis and performed clinical trials in NCCTG, ECOG, Myeloma SPORE and Mayo in the area of multiple myeloma and amyloidosis.


Representative Publications:

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis 

Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis

Ocular manifestations of Systemic Amyloidosis 

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains 


The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.